Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 2Recruiting 2Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

CNS 16Lymphoid 6Breast 5Plasma cell 3Gastrointestinal 3Thoracic 2Endocrine 2Tumor-Agnostic 1Sarcoma 1NET 1Genitourinary 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Cancer Related Cognitive Difficulties 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neuropsychological Tests × Breast × Clear all
NCT03137095 2026-04-24

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

University of Rochester

Recruiting
150 enrolled
Breast

Cancer Related Cognitive Difficulties

NCT04373564 2026-01-22

ODYSSEY

Guerbet

Phase 4 Recruiting
2,076 enrolled
BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT04835597 2024-08-26

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

M.D. Anderson Cancer Center

Terminated
27 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00550134 2021-12-30

Cognitive Changes Associated With Breast Cancer Treatment

Memorial Sloan Kettering Cancer Center

Completed
53 enrolled
Breast

Breast Neoplasms

NCT01332916 2014-04-25

CANMEM

Centre Francois Baclesse

Phase 2 Terminated
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡